Dr. Merit Cudkowicz of Massachusetts General Hospital is the lead investigator of a Phase III clinical study to evaluate the safety and effectiveness of ceftriaxone as a treatment for ALS, and to determine the safety and effectiveness of long-term use of the drug in people with ALS. Click here to find out more about this study and how you can participate.